Jun 17, 2010, 5:11 PM EDT
Michael S. Schmidt has a report in the New York Times today that last year — after Manny Ramirez came back from his drug suspension — he explored seeking an exemption from Major League Baseball in order to allow him to take drugs that would boost testosterone levels. Which, by the way, is what the drug he tested positive for last spring was designed to do.
According to Schmidt, “high-ranking Dodgers personnel, including General Manager Ned Colletti,” were involved in the discussions, and talked about whether he had enough of a
medical problem to obtain an exemption for a testosterone-boosting drug. Ultimately, however, Ramirez never sought an exemption.
Hard to say what to make of this story. If it’s true, it seems like evidence that Ramirez or those around him felt that he needed something to pick him up as he struggled in the second half last year. And if what Schmidt says is true, the Dodgers were among those thinking it.
The team denies that it took part in such discussions. I would hope their denial is truthful, because I don’t think it would be good for anyone if team brass was actually taking part in a “how can we get Manny Ramirez back on PEDs?” conversation.
(link via Dodger Thoughts)
- And That Happened: Thursday’s scores and highlights 25
- Cliff Lee placed on DL with recurrence of flexor pronator strain 25
- Winners and losers at the trade deadline 33
- 2014 Trade Deadline Tracker 49
- ACES GALORE: The Rays trade David Price to the Tigers 137
- Red Sox trade John Lackey to Cardinals for Allen Craig and Joe Kelly 89
- The Lester trade is a win-win 112
- Jon Lester, Jonny Gomes heading to Oakland for Yoenis Cespedes 165
- “Caucasians” t-shirts are hot sellers on Canadian Indian reservations (199)
- Jon Lester, Jonny Gomes heading to Oakland for Yoenis Cespedes (165)
- ACES GALORE: The Rays trade David Price to the Tigers (137)
- Rangers’ retirement gifts for Derek Jeter: Yankees cowboy boots, signed George W. Bush photo (126)
- Tampa Bay news station tweets classless Detroit joke following David Price trade (120)